{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:04:41Z","timestamp":1784531081816,"version":"3.55.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010295","name":"Nordisk Atlantsamarbejde","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013062","name":"G\u00e9nome Qu\u00e9bec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cll.2026.02.012","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:55:25Z","timestamp":1773816925000},"page":"185-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factor XIII Deficiency and Measurement"],"prefix":"10.1016","volume":"46","author":[{"given":"Catherine Pauline M.","family":"Hayward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cll.2026.02.012_bib1","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0036-1571341","article-title":"Factor XIII: structure and function","volume":"42","author":"Schroeder","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1016\/j.cll.2026.02.012_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100200","article-title":"Platelet factor XIII-A regulates platelet function and promotes clot retraction and stability","volume":"7","author":"Mitchell","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"4","key":"10.1016\/j.cll.2026.02.012_bib3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1182\/blood.2024025369","article-title":"Cryo-EM structure of the human native plasma coagulation factor XIII complex","volume":"145","author":"Singh","year":"2025","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.cll.2026.02.012_bib4","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood-2016-04-712323","article-title":"The interaction between fibrinogen and zymogen FXIII-A2B2 is mediated by fibrinogen residues gamma390-396 and the FXIII-B subunits","volume":"128","author":"Byrnes","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2026.02.012_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2025.102689","article-title":"Measurement of factor XIII for the diagnosis and management of deficiencies: insights from a retrospective review of 10 years of data on consecutive samples and patients","volume":"9","author":"Al Sharif","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.cll.2026.02.012_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.thromres.2021.06.020","article-title":"Differences in the biochemical composition of three plasma derived human fibrinogen concentrates","volume":"205","author":"Neisser-Svae","year":"2021","journal-title":"Thromb Res"},{"issue":"6","key":"10.1016\/j.cll.2026.02.012_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063055","article-title":"Factor XIII-A: an indispensable \"factor\" in haemostasis and wound healing","volume":"22","author":"Alshehri","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.cll.2026.02.012_bib8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/s-0036-1572326","article-title":"Diagnosis and management of congenital and acquired FXIII deficiencies","volume":"42","author":"Muszbek","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"10.1016\/j.cll.2026.02.012_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1042\/CS20120233","article-title":"Substrates of factor XIII-A: roles in thrombosis and wound healing","volume":"124","author":"Richardson","year":"2013","journal-title":"Clin Sci (Lond)"},{"issue":"23","key":"10.1016\/j.cll.2026.02.012_bib10","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1182\/blood-2011-02-333203","article-title":"The antifibrinolytic function of factor XIII is exclusively expressed through alpha(2)-antiplasmin cross-linking","volume":"117","author":"Fraser","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cll.2026.02.012_bib11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5482\/HAMO-13-08-0046","article-title":"Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms","volume":"34","author":"Biswas","year":"2014","journal-title":"H\u00e4mostaseologie"},{"issue":"2","key":"10.1016\/j.cll.2026.02.012_bib12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jtha.2023.09.032","article-title":"Heterozygosity in factor XIII genes and the manifestation of mild inherited factor XIII deficiency","volume":"22","author":"Singh","year":"2024","journal-title":"J Thromb Haemostasis"},{"issue":"6","key":"10.1016\/j.cll.2026.02.012_bib13","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.transci.2018.10.013","article-title":"Acquired factor XIII deficiency: a review","volume":"57","author":"Yan","year":"2018","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"10.1016\/j.cll.2026.02.012_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.blre.2016.08.002","article-title":"Autoimmune acquired factor XIII deficiency due to anti-factor XIII\/13 antibodies: a summary of 93 patients","volume":"31","author":"Ichinose","year":"2017","journal-title":"Blood Rev"},{"issue":"4","key":"10.1016\/j.cll.2026.02.012_bib15","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1160\/TH16-05-0362","article-title":"Recommendation for ISTH\/SSC criterion 2015 for autoimmune acquired factor XIII\/13 deficiency","volume":"116","author":"Ichinose","year":"2016","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.cll.2026.02.012_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12959-021-00333-3","article-title":"Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients","volume":"19","author":"Lichter","year":"2021","journal-title":"Thromb J"},{"issue":"11","key":"10.1016\/j.cll.2026.02.012_bib17","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/anae.13920","article-title":"Change of transfusion and treatment paradigm in major trauma patients","volume":"72","author":"Stein","year":"2017","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1016\/j.cll.2026.02.012_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13054-022-03940-2","article-title":"The impact of acquired coagulation factor XIII deficiency in traumatic bleeding and wound healing","volume":"26","author":"Kleber","year":"2022","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.cll.2026.02.012_bib19","first-page":"328","article-title":"Trauma induced coagulopathy and fibrinogen levels: why do we need to measure them, and what are the supplementation strategies?","volume":"35","author":"Savioli","year":"2023","journal-title":"Crit Care Sci"},{"issue":"4","key":"10.1016\/j.cll.2026.02.012_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4103\/hemoncstem.hemoncstem-D-24-00034","article-title":"Acquired factor XIII deficiency in myeloid neoplasms: case series and review of literature","volume":"17","author":"Haroon","year":"2024","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.cll.2026.02.012_bib21","article-title":"Immune-related and non-immune-related acquired factor XIII deficiency","author":"Ichinose","year":"2025","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.cll.2026.02.012_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2019.04.019","article-title":"Valproic acid-induced coagulopathy","volume":"98","author":"Kumar","year":"2019","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.cll.2026.02.012_bib23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.thromres.2016.02.026","article-title":"Non-autoimmune combined factor XIII A and B subunit deficiencies in rheumatoid arthritis patients treated with anti-interleukin-6 receptor monoclonal antibody (tocilizumab)","volume":"140","author":"Souri","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.cll.2026.02.012_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/10760296211024741","article-title":"Mild acquired factor XIII deficiency and clinical relevance at the ICU-A retrospective analysis","volume":"27","author":"Schmitt","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"issue":"4","key":"10.1016\/j.cll.2026.02.012_bib25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.sdentj.2023.03.015","article-title":"Factor XIII deficiency in the Saudi population, an underestimated bleeding risk. Review article and an illustrative case report with dental complications","volume":"35","author":"Aljabry","year":"2023","journal-title":"Saudi Dent J"},{"issue":"10","key":"10.1016\/j.cll.2026.02.012_bib26","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1007\/s10620-024-08651-y","article-title":"Acquired low factor XIII activity is associated with an increased need for blood transfusions in patients with gastrointestinal bleedings","volume":"69","author":"Traninger","year":"2024","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.cll.2026.02.012_bib27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00277-015-2568-8","article-title":"Morbidity and mortality in a large number of Iranian patients with severe congenital factor XIII deficiency","volume":"95","author":"Dorgalaleh","year":"2016","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.cll.2026.02.012_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/MBC.0000000000000374","article-title":"Establishment of a prenatal diagnosis schedule as part of a prophylaxis program of factor XIII deficiency in the southeast of Iran","volume":"27","author":"Naderi","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"3","key":"10.1016\/j.cll.2026.02.012_bib29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MBC.0000000000001121","article-title":"Noninvasive prenatal diagnosis of congenital factor XIII deficiency in Iran","volume":"33","author":"Motlagh","year":"2022","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"6","key":"10.1016\/j.cll.2026.02.012_bib30","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1111\/hae.12259","article-title":"Congenital factor XIII deficiency in women: a systematic review of literature","volume":"19","author":"Sharief","year":"2013","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.cll.2026.02.012_bib31","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","article-title":"Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the european Network of Rare Bleeding Disorders","volume":"10","author":"Peyvandi","year":"2012","journal-title":"J Thromb Haemostasis"},{"issue":"1","key":"10.1016\/j.cll.2026.02.012_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ijlh.12756","article-title":"Factor XIII deficiency diagnosis: challenges and tools","volume":"40","author":"Karimi","year":"2018","journal-title":"Int J Lab Hematol"},{"issue":"11","key":"10.1016\/j.cll.2026.02.012_bib33","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1111\/jth.13851","article-title":"Minimal factor XIII activity level to prevent major spontaneous bleeds: reply","volume":"15","author":"Menegatti","year":"2017","journal-title":"J Thromb Haemostasis"},{"issue":"1","key":"10.1016\/j.cll.2026.02.012_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/trf.12784","article-title":"Use of factor XIII (FXIII) concentrate in patients with congenital FXIII deficiency undergoing surgical procedures","volume":"55","author":"Janbain","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.cll.2026.02.012_bib35","series-title":"SickKids handbook of pediatric thrombosis and haemostasis","article-title":"Rare inherited coagulation factor deficiencies","author":"Livingston","year":"2024"},{"issue":"2","key":"10.1016\/j.cll.2026.02.012_bib36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-0038-1657331","article-title":"The half life of factor XIII in the management of inherited deficiency","volume":"49","author":"Fear","year":"1983","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cll.2026.02.012_bib37","author":"Amesse"},{"issue":"6","key":"10.1016\/j.cll.2026.02.012_bib38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.blre.2016.06.002","article-title":"Blood coagulation factor XIII and factor XIII deficiency","volume":"30","author":"Dorgalaleh","year":"2016","journal-title":"Blood Rev"},{"issue":"6","key":"10.1016\/j.cll.2026.02.012_bib39","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1538-7836.2004.00728.x","article-title":"Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency","volume":"2","author":"Lim","year":"2004","journal-title":"J Thromb Haemostasis"},{"issue":"1","key":"10.1016\/j.cll.2026.02.012_bib40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1055\/a-1481-2733","article-title":"Acquired FXIII deficiency is associated with high morbidity","volume":"122","author":"Duque","year":"2022","journal-title":"Thromb Haemost"},{"issue":"7","key":"10.1016\/j.cll.2026.02.012_bib41","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/j.1538-7836.2011.04315.x","article-title":"Diagnosis and classification of factor XIII deficiencies","volume":"9","author":"Kohler","year":"2011","journal-title":"J Thromb Haemostasis"},{"issue":"7","key":"10.1016\/j.cll.2026.02.012_bib42","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/10245332.2015.1101975","article-title":"Diagnosis of factor XIII deficiency","volume":"21","author":"Dorgalaleh","year":"2016","journal-title":"Hematology"},{"issue":"1","key":"10.1016\/j.cll.2026.02.012_bib43","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/hematology.2023000502","article-title":"Consumptive coagulopathy in the ICU","volume":"2023","author":"Retter","year":"2023","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.cll.2026.02.012_bib44","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/ijlh.12633","article-title":"Detection of factor XIII deficiency: data from multicentre exercises amongst UK NEQAS and PRO-RBDD project laboratories","volume":"39","author":"Jennings","year":"2017","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"10.1016\/j.cll.2026.02.012_bib45","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1055\/s-0034-1365841","article-title":"Factor XIII assays and associated problems for laboratory diagnosis of factor XIII deficiency: an analysis of international proficiency testing results","volume":"40","author":"Hsu","year":"2014","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"10.1016\/j.cll.2026.02.012_bib46","first-page":"491","article-title":"Laboratory diagnosis of factor XIII deficiency, routine coagulation tests with quantitative and qualitative methods","volume":"62","author":"Dorgalaleh","year":"2016","journal-title":"Clin Lab"},{"issue":"4","key":"10.1016\/j.cll.2026.02.012_bib47","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/MBC.0000000000000459","article-title":"Guidelines for laboratory diagnosis of factor XIII deficiency","volume":"27","author":"Dorgalaleh","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"5","key":"10.1016\/j.cll.2026.02.012_bib48","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1515\/cclm-2015-0547","article-title":"Measurement of factor XIII (FXIII) activity by an automatic ammonia release assay using iodoacetamide blank-procedure: no more overestimation in the low activity range and better detection of severe FXIII deficiencies","volume":"54","author":"Cini","year":"2016","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"10.1016\/j.cll.2026.02.012_bib49","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/ijlh.14111","article-title":"Iodoacetamide blank compensation in FXIII functional assays: is it still necessary?","volume":"45","author":"Savard","year":"2023","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"10.1016\/j.cll.2026.02.012_bib50","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2019.236901","article-title":"Fibrin(ogen) in human disease: both friend and foe","volume":"105","author":"Vilar","year":"2020","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.cll.2026.02.012_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12628","article-title":"Safety and effectiveness of recombinant factor XIII-A(2) in congenital factor XIII deficiency: real-world evidence","volume":"6","author":"Poulsen","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"10.1016\/j.cll.2026.02.012_bib52","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1097\/MPH.0000000000001671","article-title":"Congenital factor XIII deficiency with the presence of inhibitor: a case study","volume":"43","author":"Karaman","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.cll.2026.02.012_bib53","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1160\/TH12-12-0936","article-title":"Alloantibodies against the B subunit of plasma factor XIII developed in its congenital deficiency","volume":"109","author":"Wada","year":"2013","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.cll.2026.02.012_bib54","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0043-1764471","article-title":"Novel insights into heterozygous factor XIII deficiency","volume":"50","author":"Dorgalaleh","year":"2024","journal-title":"Semin Thromb Hemost"},{"issue":"18","key":"10.1016\/j.cll.2026.02.012_bib55","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.2169\/internalmedicine.54.4791","article-title":"Autoimmune hemorrhaphilia resulting from autoantibody against the A subunit of factor XIII","volume":"54","author":"Uchida","year":"2015","journal-title":"Intern Med"},{"issue":"5","key":"10.1016\/j.cll.2026.02.012_bib56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/MBC.0000000000001311","article-title":"Acquired factor XIII deficiency and its unprecedented association with multiple myeloma: case report and literature review","volume":"35","author":"Trabelsi","year":"2024","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.cll.2026.02.012_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.chiabu.2024.106651","article-title":"Traumatic intracranial hemorrhage in pediatrics: implications of factor XIII deficiency and consumptive coagulopathy in abusive head trauma evaluation","volume":"149","author":"Lopez","year":"2024","journal-title":"Child Abuse Negl"},{"issue":"2","key":"10.1016\/j.cll.2026.02.012_bib58","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000036944","article-title":"Abnormal bleeding after lumbar vertebrae surgery because of acquired factor XIII deficiency: a case report and literature review","volume":"103","author":"Zhang","year":"2024","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.cll.2026.02.012_bib59","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000526489","article-title":"Factor XIII in the acute care setting and its relevance in obstetric bleeding","volume":"50","author":"Duque","year":"2023","journal-title":"Transfus Med Hemotherapy"},{"issue":"1","key":"10.1016\/j.cll.2026.02.012_bib60","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1186\/s13104-018-3963-8","article-title":"Factor-XIII activity in patients with mild to moderate ulcerative colitis and active bleeding: a prospective observational study","volume":"11","author":"Bernerth","year":"2018","journal-title":"BMC Res Notes"},{"issue":"12","key":"10.1016\/j.cll.2026.02.012_bib61","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1055\/a-1450-8414","article-title":"COVID-19 is associated with an acquired factor XIII deficiency","volume":"121","author":"von Meijenfeldt","year":"2021","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.cll.2026.02.012_bib62","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.3324\/haematol.2013.089045","article-title":"Hyperfibrinolysis and acquired factor XIII deficiency in newly diagnosed pediatric malignancies","volume":"98","author":"Wiegering","year":"2013","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.cll.2026.02.012_bib63","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0002-9343(05)80019-1","article-title":"Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenstrom\u2019s macroglobulinemia","volume":"90","author":"Krumdieck","year":"1991","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.cll.2026.02.012_bib64","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1365-2516.2008.01857.x","article-title":"Factor XIII deficiency","volume":"14","author":"Hsieh","year":"2008","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.cll.2026.02.012_bib65","first-page":"E57","article-title":"Association between factor XIII activity and clinical course in pediatric patients with immunoglobulin A vasculitis","volume":"69","author":"Tanaka","year":"2023","journal-title":"Kobe J Med Sci"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271226000120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271226000120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:29:43Z","timestamp":1784528983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271226000120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0272271226000120"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2026.02.012","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factor XIII Deficiency and Measurement","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2026.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}